Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Emphysema Treatment Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The emphysema treatment market size has experienced robust growth in recent years. This market is projected to expand from $5.4 billion in 2025 to $5.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. The expansion observed in the historic period is attributable to the increasing prevalence of COPD, a growing smoking population, limited awareness of early diagnosis, the adoption of traditional inhalation therapies, and the rising hospital infrastructure in developing regions.
The emphysema treatment market is anticipated to experience robust expansion in the coming years. This market is projected to reach $7.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period is propelled by factors such as progress in gene therapy, increased uptake of digital health solutions, expanding home , the creation of portable oxygen devices, and a heightened need for minimally invasive surgical procedures. Key trends influencing the market over the forecast period encompass tailored treatment plans, in-home care options, less invasive therapeutic approaches, remote patient monitoring via telehealth, and sophisticated pulmonary rehabilitation programs.
Get A Free Sample Report With In-Depth Market Insights:
Emphysema Treatment Market Growth Momentum: What Factors Are Shaping Demand?
The increasing incidence of chronic obstructive pulmonary disease (COPD) cases is anticipated to drive expansion in the emphysema treatment market in the future. Chronic obstructive pulmonary disease (COPD) encompasses a group of conditions leading to obstructed airflow and challenges with breathing, such as emphysema and chronic bronchitis. Treatments for emphysema are crucial for slowing the progression of Chronic Obstructive Pulmonary Disease (COPD) because they aim to manage symptoms, recover lung functionality, and impede the disease’s advancement. For example, a research study published in December 2023 by JAMA Network Open, a medical journal from the American Medical Association, indicated that the global caseload of chronic obstructive pulmonary disease (COPD) could approach 600 million globally by 2050, representing a 23% rise in its prevalence. Consequently, the growing prevalence of chronic obstructive pulmonary disease (COPD) cases is a key factor propelling the emphysema treatment market.
Emphysema Treatment Market Segment Breakdown: Which Categories Lead On Revenue?
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care
Emphysema Treatment Market Trends Redefining Industry Growth
Leading companies operating within the emphysema market are actively developing innovative products, such as inhalation aerosols, to gain a competitive advantage. Inhalation aerosols are pharmaceutical formulations delivered as a fine mist or spray, where liquid medication is suspended in a propellant or a blend of propellants. For example, in July 2023, Viatris Inc., a US-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a US-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This launch marked the first FDA-approved generic version of AstraZeneca’s Symbicort for patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. This drug-device combination product, available in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, represents a significant stride in providing accessible and cost-effective treatment options for individuals facing respiratory challenges. Breyna is intended for the maintenance treatment of airflow obstruction, to reduce exacerbations in COPD patients, and to manage asthma symptoms in patients six years and older, including those with emphysema.
Emphysema Treatment Market Leading Players And Competitive Positioning
Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.
View The Full Emphysema Treatment Market Report:
Emphysema Treatment Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
